VEC.L Share News (VEC)

LONDON MARKET CLOSE: Oil Rally Helps FTSE 100 To Highest 2016 Close

LONDON MARKET MIDDAY: "Risky" Oil Price Rally Supports Stocks

WINNERS & LOSERS SUMMARY: Pathfinder Sinks After Mozambique Ruling

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

US Accepts Hikma, Vectura Filing For Generic Of Glaxo's Advair Diskus

Broker tips: ARM, Tate & Lyle, Inchcape

(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura. After another strong set of quarterly results, ARM remains the top pick as Numis

Numis adds Virgin Money, Derwent and Northgate to 'top picks' list

(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura. After another strong set of quarterly results, ARM remains the top pick as Numis

Vectura receives support from Skyepharma shareholder

(ShareCast News) - Vectura - which focuses on the development of pharmaceutical therapies for airways diseases - has received a letter of intent from a Skyepharma shareholder supporting the companies' proposed merger. Vectura said River and Mercantile Asset Management, which owns just under 4.8m Sky

Vectura Gets Support From Skyepharma Shareholder For Takeover (ALLISS)

UPDATE 1-Vectura to buy SkyePharma for $620 mln as UK biotech consolidates

* Agreed offer values SkyePharma at 410.15 pence a share * Combined group market value more than 1 billion pounds (Adds more on rationale for deal, comment from CEO) By Ben Hirschler LONDON, March 16 (Reuters) - Respiratory drug specialist Vectura has agreed to buy rival SkyeP

Skyepharma Agrees To Merge With Vectura As It Swings To Profit (ALLISS)

Skyepharma and Vectura agree merger; Skyepharma swings to profit

(ShareCast News) - Vectura and Skyepharma have reached an agreement on the terms of a recommended merger. Under the terms of the deal, Skyepharma shareholders will get 2.7977 new Vectura shares for each Skyepharma share. Based on Vectura's closing price of 146.60p on Tuesday, this values Skyepharma

Wednesday broker round-up

(ShareCast News) - Virgin Money: Nomura starts coverage at buy with a target of 445p. Domino's Pizza: Credit Suisse upgrades to outperform with a target price of 1100p. BBA Aviation: Goldman Sachs downgrades to neutral with 181p target. Greencore: Societe Generale reiterates hold with a 386p targe

Milestone payday for Vectura on new asthma therapy

(ShareCast News) - Vectura Group's inhaler and formulation technology received a boost on Wednesday, with the completion of a significant milestone on the development of the VR315 product. The FTSE 250 company confirmed that the clinical study report had been finalised, triggering a cash milestone p

Vectura Gets GBP2 Million Milestone Payment After VR315 Trial